Lehman Brothers research : an analyst decides that the market overreacted to Merck's Vioxx woes /
In September 2004, Merck announced a voluntary withdrawal of Vioxx, one of its top earning drugs, after a new study suggested that it increased the risk of heart attacks. In only a few days, Merck's share price collapsed, and nearly $25 billion in shareholder wealth was erased. This case examin...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
[London] :
SAGE,
2016.
|
| Series: | SAGE knowledge. Cases.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | In September 2004, Merck announced a voluntary withdrawal of Vioxx, one of its top earning drugs, after a new study suggested that it increased the risk of heart attacks. In only a few days, Merck's share price collapsed, and nearly $25 billion in shareholder wealth was erased. This case examines the market reaction to Merck's product recall. |
|---|---|
| Item Description: | Originally Published in: Hutchins, S. (2006). Lehman Brothers Research: An Analyst Decides that the Market Overreacted to Merck's Vioxx Woes. 06-014. New Haven, CT: Yale School of Management, Yale University. |
| Physical Description: | 1 online resource : illustrations (black and white, and colour). |
| ISBN: | 9781473974418 (ebook) : |